Top 5 Oil Service Companies To Buy Right Now

Top 5 Oil Service Companies To Buy Right Now: Aastrom Biosciences Inc.(ASTM)

Aastrom Biosciences, Inc., a regenerative medicine company, engages in developing autologous cell therapies for the treatment of severe and chronic cardiovascular diseases. The company?s autologous expanded cellular therapy technology uses single-pass perfusion to produce human cell products for clinical use. Its clinical development programs include CLI program, which is in phase IIb clinical development for the treatment of serious and advanced stage of peripheral arterial diseases; and DCM development program, which is in Phase II for the treatment of dilated cardiomyopathy (DCM). The company also has two ongoing U.S. Phase II trials investigating surgical and catheter-based delivery for its product in the treatment of DCM. Aastrom Biosciences, Inc. was founded in 1989 and is headquartered in Ann Arbor, Michigan.

Advisors' Opinion:

• [By John Udovich]

  At the end of this week, congressional scrutiny was weighting down large cap biotech Gilead Sciences, Inc (NASDAQ: GILD) and dragging down much of the biotech sector, but there was still good news surrounding small cap biotech stocks like Endocyte, Inc (NASDAQ: ECYT), Aastrom Biosciences Inc (NASDAQ: ASTM) and TNI BioTech (OTCMKTS: TNIB) plus there were more biotech IPOs which debuted:

• [By Roberto Pedone]

   

   

  Another under-$10 biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Aastrom Biosciences (ASTM), which is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues. This stock has trended modestly lower over the last three months, with shares off by 4.9%.

  If you take a look at the chart for Aastrom Biosciences, you'll notice that this stock just recently formed ! a double bottom chart pattern at $3.16 to $3.14 a share over the last month and change. Following that bottom, shares of ASTM have started to spike higher and move back above its 50-day moving average of $3.58 a share. That move is quickly pushing shares of ASTM within range of triggering a big breakout trade.

  Market players should now look for long-biased trades in ASTM if it manages to break out above some near-term overhead resistance at $4.50 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 140,540 shares. If that breakout hits soon, then ASTM will set up to re-test or possibly take out its next major overhead resistance levels at $6.25 to $6.80 a share. Any high-volume move above those levels will then give ASTM a chance to re-fill some of its previous gap-down-zone from last August that started at $12 a share.

  Traders can look to buy ASTM off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $3.58 a share. One can also buy ASTM off strength once it starts to clear $4.50 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By James E. Brumley]

  With just a quick glance, Aastrom Biosciences Inc. (NASDAQ:ASTM) doesn't look like any less of a disaster today than it did a week ago, a month ago, or even a year ago. But, the longer you look at ASTM, the more it seems it may have already hit its ultimate bottom, and is now biding its time to start the rebound.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-5-oil-service-companies-to-buy-right-now-3.html